奥美医疗
(002950)
| 流通市值：33.58亿 | | | 总市值：47.05亿 |
| 流通股本：4.52亿 | | | 总股本：6.33亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,018,286,601.72 | 1,426,718,393.59 | 814,642,103.91 | 4,210,502,651.18 |
| 营业收入 | 2,018,286,601.72 | 1,426,718,393.59 | 814,642,103.91 | 4,210,502,651.18 |
| 二、营业总成本 | 1,807,626,230.75 | 1,230,103,236.6 | 678,212,282.59 | 3,557,088,687.6 |
| 营业成本 | 1,417,410,619.91 | 983,880,236.34 | 541,999,859.85 | 2,793,849,892.67 |
| 税金及附加 | 13,186,520.6 | 9,330,367.12 | 5,273,234.04 | 26,473,078.61 |
| 销售费用 | 45,098,936.12 | 31,393,116.28 | 22,730,090 | 83,796,019.27 |
| 管理费用 | 253,194,609.63 | 167,797,056.72 | 90,809,923.47 | 365,952,206.74 |
| 研发费用 | 60,060,955.75 | 38,036,701.83 | 21,823,941.49 | 107,735,053.2 |
| 财务费用 | 18,674,588.74 | -334,241.69 | -4,424,766.26 | 179,282,437.11 |
| 其中:利息费用 | 24,589,365.72 | 16,623,019.76 | 10,574,807.26 | 35,470,555.17 |
| 其中:利息收入 | 1,263,228.97 | 735,802.86 | 454,651.7 | 3,090,904.7 |
| 加:公允价值变动收益 | 55,670,013.67 | 51,648,647.68 | 61,097,413.56 | -57,564,992.88 |
| 加:投资收益 | -61,837,314.13 | -51,073,448.09 | -47,329,724.46 | -102,620,427.19 |
| 资产处置收益 | 31,644.97 | 31,644.97 | 36,082.01 | 3,497,141.53 |
| 资产减值损失(新) | -26,367,100.44 | -12,930,047.43 | -6,349,347.98 | -14,782,797.37 |
| 信用减值损失(新) | 3,083,497.72 | 2,079,203.38 | 281,010.15 | -1,729,308.7 |
| 其他收益 | 15,838,536.53 | 10,712,483.64 | 5,290,246.19 | 44,858,888.75 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 197,079,649.29 | 197,083,641.14 | 149,455,500.79 | 525,072,467.72 |
| 加:营业外收入 | 1,658,636.49 | 993,076.67 | 31,621.61 | 1,485,940.47 |
| 减:营业外支出 | 1,285,458.76 | 632,772.81 | 198,845.4 | 41,653,471.13 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 197,452,827.02 | 197,443,945 | 149,288,277 | 484,904,937.06 |
| 减:所得税费用 | 52,356,773.14 | 42,534,543.02 | 22,384,426.72 | 80,255,568.78 |
| 六、净利润 | 145,096,053.88 | 154,909,401.98 | 126,903,850.28 | 404,649,368.28 |
| 持续经营净利润 | 145,096,053.88 | 154,909,401.98 | 126,903,850.28 | 404,649,368.28 |
| 归属于母公司股东的净利润 | 150,405,071.8 | 157,039,396.67 | 127,884,816.36 | 406,798,486.27 |
| 少数股东损益 | -5,309,017.92 | -2,129,994.69 | -980,966.08 | -2,149,117.99 |
| (一)基本每股收益 | 0.24 | 0.25 | 0.2 | 0.64 |
| (二)稀释每股收益 | 0.24 | 0.25 | 0.2 | 0.64 |
| 八、其他综合收益 | -2,214,144.71 | -2,198,035.26 | -23,302,382.65 | 77,944,056.38 |
| 归属于母公司股东的其他综合收益 | -2,214,144.71 | -2,198,035.26 | -23,302,382.65 | 77,944,056.38 |
| 九、综合收益总额 | 142,881,909.17 | 152,711,366.72 | 103,601,467.63 | 482,593,424.66 |
| 归属于母公司股东的综合收益总额 | 148,190,927.09 | 154,841,361.41 | 104,582,433.71 | 484,742,542.65 |
| 归属于少数股东的综合收益总额 | -5,309,017.92 | -2,129,994.69 | -980,966.08 | -2,149,117.99 |
| 公告日期 | 2023-10-28 | 2023-08-30 | 2023-04-29 | 2023-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |